Advanced Herbal Approaches to Diabetes and Metabolic Disorders: Current Status and Future Prospects
DOI:
https://doi.org/10.22270/ajprd.v14i5.1872Abstract
Diabetes and related metabolic issues are major health problems around the world. In many cases, blood sugar is not well controlled. Insulin may not work as it should. Levels of fats in the blood can also become abnormal. Over time, oxidative stress builds up. Mild inflammation tends to continue too. Many people do benefit from common drug therapy. Even so, some medicines lead to side effects. In other cases, the response is not strong enough. Because these conditions come from more than one cause, interest in herbal options has grown. Researchers are examining plant compounds as possible supportive choices. This review explains the current status of herbal approaches. It also looks at what might happen next. Topics include the main chemicals found in these plants. It covers possible ways those chemicals may act in the body. It then summarizes what clinical studies report and how ready the evidence is for everyday use. The review also groups plant chemical types into several categories. The review covers both lab work and tests in people. It looks at medicinal plants as well as specific plant chemicals. Absorption is a key focus. Safety is discussed too, including side risks and possible clashes between herbs and drugs. Product strength is another concern. Extracts can differ a lot between one batch and the next.New ways to deliver these compounds are also included. The text mentions nanoparticles, phytosomes, liposomes, and other carriers. These systems may improve water solubility. They may also help compounds stay stable. Better uptake in the body is another point. If uptake improves, the effects in treatment could be stronger.For future work, the authors highlight multi target strategies. They also bring up metabolomics and plans that can be adjusted for each person. They suggest that artificial intelligence could aid trial design and data review. They emphasize the need for products that stay consistent and are well standardized. More toxicology studies are needed. More work on pharmacokinetics is also important. Finally, clinical trials should be planned better so herbal options for metabolic problems can be judged with solid evidence.
Downloads
References
Antar S.A., Ashour N.A., Sharaky M., Khattab M., Ashour N.A., Zaid R.T., Roh E.J., Elkamhawy A., Al-Karmalawy A.A. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed. Pharmacother. 2023;168:115734. doi: 10.1016/j.biopha.2023.115734. [DOI] [PubMed] [Google Scholar]
World Health Organization . Diabetes. WHO; Genave, Switzerland: 2024. [(accessed on 14 November 2024)]. Available online: https://www.who.int/news-room/fact-sheets/detail/diabetes. [Google Scholar]
Shaikh A.A., Kolhatkar M.K., Sopane D.K., Thorve A.N. Review on: Diabetes mellitus is a disease. Int. J. Res. Pharm. sSci. 2022;13:102–109. doi: 10.26452/ijrps.v13i1.27. [DOI] [Google Scholar]
Bastaki S. A review diabetes mellitus and its treatment. Int. J. Diabetes Metab. 2005;13:111–134. doi: 10.1159/000497580. [DOI] [Google Scholar]
Dey R.K. Diabetes Mellitus: A comprehensive review of pathophysiology, management, and emerging therapeutic approaches. Diabetes Mellitus. 2023;6:96–100. [Google Scholar]
Mishra R, Pal R, Khan Z, Sahoo S, Chawra HS, Kumar D. Solid lipid nanoparticles (SLNPs): a state-of-the-art formulation strategy and their applications against tuberculosis (TB) and analgesic effects. Nanoscience & Nanotechnology-Asia. 2025 Jun;15(3):E22106812379362.
Lu X., Xie Q., Pan X., Zhang R., Zhang X., Peng G., Zhang Y., Shen S., Tong N. Type 2 diabetes mellitus in adults: Pathogenesis, prevention and therapy. Sig. Transduct. Target. Ther. 2024;9:262–286. doi: 10.1038/s41392-024-01951-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tegegne B.A., Adugna A., Yenet A., Yihunie Belay W., Yibeltal Y., Dagne A., Hibstu Teffera Z., Amare G.A., Abebaw D., Tewabe H., et al. A critical review on diabetes mellitus type 1 and type 2 management approaches: From lifestyle modification to current and novel targets and therapeutic agents. Front. Endocrinol. 2024;15:1440456–1440475. doi: 10.3389/fendo.2024.1440456. [DOI] [PMC free article] [PubMed] [Google Scholar]
Yameny A.A. Diabetes mellitus overview. J. Biosci. Appl. Res. 2024;10:641–645. doi: 10.21608/jbaar.2024.382794. [DOI] [Google Scholar]
Kaur S., Gadpayle D., Kumari A., Kaur G., Seen K., Bhardwaj R., Kumar A. Antidiabetic potential of underutilized crops: Nutritional, phytochemical insights, and prospects for diabetes management. Appl. Food Res. 2025;5:101127. doi: 10.1016/j.afres.2025.101127. [DOI] [Google Scholar]
Chanda S., Ramachandra T.V. A review on some therapeutic aspects of phytochemicals present in medicinal plants. Int. J. Pharm. Life Sci. 2019;10:6052–6058. [Google Scholar]
Nafiu M.O., Hamid A.A., Muritala H.F., Adeyemi S.B. Medicinal Plants: Ethnopharmacology, Phytochemistry and Therapeutic Applications. Elsevier; Amsterdam, The Netherlands: 2023. Preparation, Standardization, and Quality Control of Medicinal Plants in Africa. Chapter 7. [DOI] [Google Scholar]
Whaley A.O., Whaley A.K., Kovaleva E.L., Frolova L.N., Orlova A.A., Luzhanin V.G., Flisyiuk E.V., Shigarova L.V., Pozharitskaya O.N., Shikov A.N. The Standardization of Officinal Medicinal Plants Used in the Eurasian Economic Union: Comparison with Other Pharmacopoeias. Pharm. Chem. J. 2024;23:349–419. doi: 10.1007/s11101-023-09887-8. [DOI] [Google Scholar]
Gupta U, Kosey S, Pal R. Advancements in nanotechnology-based targeted drug delivery systems for glioblastoma chemotherapy: A comprehensive review. Journal of Drug Delivery Science and Technology. 2025 Sep 1;111:107181.
Forni C., Facchiano F., Bartoli M., Pieretti S., Facchiano A., D’Arcangelo D., Norelli S., Valle G., Nisini R., Beninati S., et al. Beneficial Role of Phytochemicals on Oxidative Stress and Age-Related Diseases. Biomed. Res. Int. 2019;2019:1–16. doi: 10.1155/2019/8748253. [DOI] [PMC free article] [PubMed] [Google Scholar]
Al-Ishaq R.K., Overy A.J., Büsselberg D. Phytochemicals and Gastrointestinal Cancer: Cellular Mechanisms and Effects to Change Cancer Progression. Biomolecules. 2020;10:105. doi: 10.3390/biom10010105. [DOI] [PMC free article] [PubMed] [Google Scholar]
Begum V.S.M., Tariq N.P.M., Hemapriya J., Shariq K.M. Plants Secondary Metabolites as Medicines: A Review. IJZI. 2022;8:490–493. doi: 10.33745/ijzi.2022.v08i01.056. [DOI] [Google Scholar]
Enioutina E.Y., Salis E.R., Job K.M., Gubarev M.I., Krepkova L.V., Sherwin C.M.T. Herbal Medicines: Challenges in the modern world. Part 5. Status and current directions of complementary and alternative herbal medicine worldwide. Expert Rev. Clin. Pharmacol. 2016;10:327–338. doi: 10.1080/17512433.2017.1268917. [DOI] [PubMed] [Google Scholar]
Pérez-Flores J.G., García-Curiel L., Pérez-Escalante E., Contreras-López E., Aguilar-Lira G.Y., Ángel-Jijón C., González-Olivares L.G., Baena-Santillán E.S., Ocampo-Salinas I.O., Guerrero-Solano J.A., et al. Plant Antimicrobial Compounds and Their Mechanisms of Action on Spoilage and Pathogenic Bacteria: A Bibliometric Study and Literature Review. Appl. Sci. 2025;15:3516. doi: 10.3390/app15073516. [DOI] [Google Scholar]
Verma S, Panday D, Vasanthi AV, Sahoo S, Roli, Yadav A, Ghosh B, Pal R. Micro Novel Carriers: Reshaping Tuberculosis Therapy by Targeting Alveolar Macrophages, Reducing Drug Resistance, and Shortening Treatment Durations-A 2020-2025 Comprehensive Review. Recent Patents on Nanotechnology. 2026.
Sundaram M.K., Khan M.A., Alalami U., Somvanshi P., Bhardwaj T., Pramodh S., Raina R., Shekfeh Z., Haque S., Hussain A. Phytochemicals induce apoptosis by modulation of nitric oxide signaling pathway in cervical cancer cells. Eur. Rev. Med. Pharmacol. Sci. 2020;24:11827–11844. doi: 10.26355/eurrev_202011_23840. [DOI] [PubMed] [Google Scholar]
Lin R., Hu X., Chen S., Shi Q., Chen H. Naringin induces endoplasmic reticulum stress-mediated apoptosis, inhibits β-catenin pathway and arrests cell cycle in cervical cancer cells. Acta Biochim. Pol. 2020;67:181–186. doi: 10.18388/abp.2020_5182. [DOI] [PubMed] [Google Scholar]
Mahmoud V.L., Shayesteh R., Foong Yun Loh T.K., Chan S.W., Sethi G., Burgess K., Lee S.H., Wong W.F., Looi C.Y. Comprehensive Review of Opportunities and Challenges of Ethnomedicinal Plants for Managing Type 2 Diabetes. Heliyon. 2024;10:e39699. doi: 10.1016/j.heliyon.2024.e39699. [DOI] [PMC free article] [PubMed] [Google Scholar]
Hui H., Tang G., Go V. Hypoglycemic Herbs and Their Action Mechanisms. Chin. Med. 2009;4:11. doi: 10.1186/1749-8546-4-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kooti W., Farokhipour M., Asadzadeh Z., Ashtary-Larky D., Asadi-Samani M. The Role of Medicinal Plants in the Treatment of Diabetes: A Systematic Review. Electron. Physician. 2016;8:1832–1842. doi: 10.19082/1832. [DOI] [PMC free article] [PubMed] [Google Scholar]
Salleh N.H., Zulkipli I.N., Mohd Yasin H., Ja’afar F., Ahmad N., Wan Ahmad W.A.N., Ahmad S.R. Systematic Review of Medicinal Plants Used for Treatment of Diabetes in Human Clinical Trials: An ASEAN Perspective. Evid.-Based Complement. Altern. Med. 2021;2021:5570939. doi: 10.1155/2021/5570939. [DOI] [PMC free article] [PubMed] [Google Scholar]
Pal R, Ghosh B, Dutta P, Mukeshkumar Shah T, Singh A. Cutting-edge nano novel drug delivery carriers (NDCs) for tuberculosis (TB) management: insights into clinical trials and patent landscape. Journal of Microencapsulation. 2026 Jun 13:1-31.
Mourya R., Sharma R. Interaction Between Anti-Diabetic Drugs and Herbs: A Review. Pharmacogn. Res. 2025;17:385–401. doi: 10.5530/pres.20252023. [DOI] [Google Scholar]
Dash J.R., Kar B., Pattnaik G. Pharmacological Interaction Between Anti-Diabetic Drugs and Herbs: An Overview of Mechanism of Action and Clinical Implication. Plant Arch. 2020;20:3661–3668. [Google Scholar]
Li X., Geng-Ji J.-J., Quan Y.-Y., Qi L.-M., Sun Q., Huang Q., Jiang H.-M., Sun Z.-J., Liu H.-M., Xie X. Role of Potential Bioactive Metabolites from Traditional Chinese Medicine for Type 2 Diabetes Mellitus: An Overview. Front. Pharmacol. 2022;13:1023713. doi: 10.3389/fphar.2022.1023713. [DOI] [PMC free article] [PubMed] [Google Scholar]
Chattopadhyay K., Wang H., Kaur J., Nalbant G., Almaqhawi A., Kundakci B., Panniyammakal J., Heinrich M., Lewis S.A., Greenfield S.M., et al. Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis. Front. Pharmacol. 2022;13:821810. doi: 10.3389/fphar.2022.821810. [DOI] [PMC free article] [PubMed] [Google Scholar]
Shukla K, S V, Mishra R, Sahoo S, Saxena G, Shah TM, Rahaman A, Chawra HS, Pal R. Nanoparticles (NPs) as a cutting-edge therapeutic strategy and their current status in tuberculosis (TB): a comprehensive review. Recent Advances in Drug Delivery and Formulation. 2026.
Zanzabil K.Z., Hossain M.S., Hasan M.K. Diabetes mellitus management: An extensive review of 37 medicinal plants. Diabetology. 2023;4:186–234. doi: 10.3390/diabetology4020019. [DOI] [Google Scholar]
Asiago O.H., Reddy K.S. Protective effect of achyranthes aspera against high fat diet and streptozotocin induced diabetes in rats [Adventure] J. Chem. Health Risks. 2023;13:3124–3131. [Google Scholar]
Vijayaraj R., Naresh Kumar K., Mani P., Senthil J., Jayaseelan T., Dinesh Kumar G. Hypoglycemic and antioxidant activity of Achyranthes aspera seed extract and its effect on streptozotocin induced diabetic rats. Int. J. Biol. Pharm. Res. 2016;7:23–28. doi: 10.1016/S2221-1691(11)60051-8. [DOI] [Google Scholar]
Priyamvada P.M., Mishra P., Sha A., Mohapatra A.K. Evaluation of antidiabetic and antioxidant activities of Achyranthes aspera leaf extracts: An in vitro study. Int. J. Pharm. Life Sci. 2021;10:103–110. [Google Scholar]
Njideka B.E., Theophilus A.E.N., Ugochukwu N.T. Use of Achyranthes aspera Linn Tea as antidiabetic and hypolipidemic herbal tea. Int. J. Health Sci. Res. 2019;9:32–38. [Google Scholar]
Sanie-Jahromi F., Zia Z., Afarid M. A review on the effect of garlic on diabetes, BDNF, and VEGF as a potential treatment for diabetic retinopathy. Chin. Med. 2023;18:18–31. doi: 10.1186/s13020-023-00725-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
Xie C., Gao W., Li X., Luo S., Wu D., Chye F.Y. Garlic (Allium sativum L.) polysaccharide ameliorates type 2 diabetes mellitus (T2DM) via the regulation of hepatic glycogen metabolism. NFS J. 2023;31:19–27. doi: 10.1016/j.nfs.2023.02.004. [DOI] [Google Scholar]
Ghosh B, Sharma P, Goyal S, Chaturvedi V, Reena K, Pal R. Next-Generation Nanocarriers-Based Nanoformulations for Polycystic Ovary Syndrome (PCOS): A Deep Insight into Clinical and Patents Perspectives. Drug Delivery Letters. 2026.
Abdullah H., Miladiyah I. Garlic (Allium sativum L.) Efficacy as an adjuvant therapy for type 2 diabetes mellitus: A scoping review. In: Nurdiyanto H., Miladiyah I., Jamil N.A., editors. Proceedings of the 3rd International Conference on Cardiovascular Diseases (ICCvD 2021) Atlantis Press International BV; Paris, France: 2023. pp. 419–434. [DOI] [Google Scholar]
Harshali, Thakur P., Mukherjee G. Aloe Vera as an Antidiabetic and Wound Healing Agent for Diabetic Patients. JPRI. 2021;33:256–263. doi: 10.9734/jpri/2021/v33i57A33994. [DOI] [Google Scholar]
Zhang Y., Liu W., Liu D., Zhao T., Tian H. Efficacy of Aloe Vera supplementation on prediabetes and early non-treated diabetic patients: A Systematic review and meta-analysis of randomized controlled trials. Nutrients. 2016;8:388. doi: 10.3390/nu8070388. [DOI] [PMC free article] [PubMed] [Google Scholar]
Budiastutik I., Subagio H.W., Kartasurya M.I., Widjanarko B., Kartini A., Soegiyanto S., Suhartono S.S. The effect of aloe vera on fasting blood glucose levels in pre-diabetes and type 2 diabetes mellitus: A systematic review and meta-analysis. J. Pharm. Pharmacogn. Res. 2022;10:737–747. doi: 10.56499/jppres22.1378_10.4.737. [DOI] [Google Scholar]
Abo-Youssef A.M.H., Messiha B.A.S. Beneficial effects of aloe vera in treatment of diabetes: Comparative in vivo and in vitro studies. Bull. Fac. Pharm. Cairo Univ. 2013;51:7–11. doi: 10.1016/j.bfopcu.2012.03.002. [DOI] [Google Scholar]
Amar K, Sahoo S, Mishra R, Dutta P, Ghosh B, Pal R. Lipidic nanocarriers (liposomes): A potential targeting strategy for cosmeceutical and therapeutic applications—an in-depth review. Curr Nanomed. 2026;16.
Rahman A.H.M.M., Iffat Ara Gulshana M. Taxonomy and medicinal uses on amaranthaceae family of rajshahi, Bangladesh. AEES. 2014;2:54–59. doi: 10.12691/aees-2-2-3. [DOI] [Google Scholar]
Aneja S., Vats M., Aggarwal S., Sardana S. Phytochemistry and hepatoprotective activity of aqueous extract of Amaranthus tricolor Linn. Roots. J. Ayurveda Integr. Med. 2013;4:211–217. doi: 10.4103/0975-9476.123693. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rahmatullah M., Hosain M., Rahman S., Rahman S., Akter M., Rahman F., Rehana F., Munmun M., Kalpana M. antihyperglycemic and antinociceptive activity evaluation of methanolic extract of whole plant of Amaranthus Tricolor L. (Amaranthaceae) Afr. J. Tradit. Complement. Altern. Med. 2013;10:408–411. doi: 10.4314/ajtcam.v10i5.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
Rahma K., Nurcahyanti O. Therapeutic effect of red spinach (Amaranthus tricolor L.) extract on pancreatic MDA levels rats (Rattus norvegicus) exposed to MLD-STZ. J. Biomed. Transl. Res. 2021;7:129–133. doi: 10.14710/jbtr.v7i3.12536. [DOI] [Google Scholar]
Singh A, Mandal RK, Sahoo S, Shah TM, Pal R. Gastro-Retentive Drug Delivery Systems (GRDDs) as a Promising Strategy for Disease Targeting: A Comprehensive Review. Drug Delivery Letters. 2026.
Ajao F.O., Iyedupe M.O., Akanmu O., Kalejaiye N.O., Adegoke A.L., Adeniji L.A. Anti-oxidative, anti-inflammatory and anti-apoptotic efficacy of Anacardium occidentale leaf extract in diabetic rats. Int. J. Diabetes Clin. Res. 2023;10:177–188. doi: 10.23937/2377-3634/1410177. [DOI] [Google Scholar]
Vasanth S, Mishra R, Sahoo S, Parveen S, Khan Z, Mumtaz, Ruqaiya, Pal R. Advancing mitochondrial health in Huntington disease (HD): small molecule therapies and neurodegeneration. Current aging science. 2025.
Ponce-Mora A., Gimeno-Mallench L., Lavandera J.L., Giebelhaus R.T., Domenech-Bendaña A., Locascio A., Gutierrez-Rojas I., Sauro S., De La Mata P., Nam S.L., et al. Systematic Characterization of Antioxidant Shielding Capacity Against Oxidative Stress of Aerial Part Extracts of Anacardium occidentale. Antioxidants. 2025;14:935. doi: 10.3390/antiox14080935. [DOI] [PMC free article] [PubMed] [Google Scholar]
Abdullahi S., Olatunji G.A. Antidiabetic activity of Anacardium occidentale in alloxan—Diabetic rats. Jnl Sci. Tech. 2010;30:35–41. doi: 10.4314/just.v30i3.64622. [DOI] [Google Scholar]
Olatunji L.A., Okwusidi J.I., Soladoye A.O. Antidiabetic effect of Anacardium occidentale. Stem-bark in fructose-diabetic rats. Pharm. Biol. 2005;43:589–593. doi: 10.1080/13880200500301712. [DOI] [Google Scholar]
Ukwenya V.O., Alese M.O., Ogunlade B., Folorunso I.M., Omotuyi O.I. Anacardium occidentale leaves extract and riboceine mitigate hyperglycemia through anti-oxidative effects and modulation of some selected genes associated with diabetes. J. Diabetes Metab. Disord. 2022;22:455–468. doi: 10.1007/s40200-022-01165-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
Koli M, Shah TM, Dutta P, Patel N, Patel AK, Ghosh B, Singh A, Pal R. Non-Ionic Surfactants (NIOs) in Niosome Drug Delivery: In-Depth Review of Clinical Trials, Patents in Tuberculosis (TB) and Oncology. Current Nanomedicine. 2025.
Almalki G., Alothman N., Mohamed G., Akeel M., El-Beltagy A.E.-F.B.M., Salem E.T. Modulatory role of Annona squamosa extract against streptozotocin-induced diabetic nephropathy in male rats. Egypt. J. Basic Appl. Sci. 2024;11:536–556. doi: 10.1080/2314808X.2024.2366610. [DOI] [Google Scholar]
Sharma A., Chand T., Khardiya M., Yadav K.C., Mangal R., Sharma A.K. Antidiabetic and antihyperlipidemic activity of Annona squamosa fruit peel in streptozotocin induced diabetic rats. Int. J. Pharm. Sci. Res. 2013;4:200–208. [Google Scholar]
Gupta R.K., Kesari A.N., Watal G., Murthy P.S., Chandra R., Maithal K., Tandon V. Hypoglycaemic and antidiabetic effect of aqueous extract of leaves of Annona squamosa (L.) in experimental animals. Curr. Sci. 2005;88:1192–1196. doi: 10.1016/j.jep.2005.01.048. [DOI] [PubMed] [Google Scholar]
Kaleem M., Asif M., Ahmed Q.U., Bano B. Antidiabetic and antioxidant activity of Annona squamosa extract in streptozotocin-induced diabetic rats. Singap. Med. J. 2006;47:670–675. [PubMed] [Google Scholar]
Muszalska A., Wiecanowska J. Berberis vulgaris: A natural source of berberine for addressing contemporary health concerns. Herba. Pol. 2024;70:13–38. doi: 10.5604/01.3001.0054.7646. [DOI] [Google Scholar]
Pang B., Zhao L.-H., Zhou Q., Zhao T.-Y., Wang H., Gu C.-J., Tong X.-L. Application of berberine on treating type 2 diabetes mellitus. Int. J. Endocrinol. 2015;2015:905749. doi: 10.1155/2015/905749. [DOI] [PMC free article] [PubMed] [Google Scholar]
Meliani N., Dib M.E.A., Allali H., Tabti B. Hypoglycaemic effect of Berberis vulgaris L. in normal and streptozotocin-induced diabetic rats. Asian Pac. J. Trop. Biomed. 2011;1:468–471. doi: 10.1016/S2221-1691(11)60102-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
Published
How to Cite
Issue
Section
Copyright (c) 2026 Ajita S. Kesharwani, Palak Ghanshyam Rahangdale, Rashmi Khanijau, Naveen Jain, Hriddhi Chakraborty
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
. 